ClinVar Miner

Submissions for variant NM_000548.5(TSC2):c.4258_4261del (p.Ser1420fs)

dbSNP: rs137854132
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Mendelics RCV000989436 SCV001139759 pathogenic Tuberous sclerosis 2 2019-05-28 criteria provided, single submitter clinical testing
Invitae RCV000989436 SCV001592673 pathogenic Tuberous sclerosis 2 2023-12-25 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Ser1420Glyfs*55) in the TSC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TSC2 are known to be pathogenic (PMID: 10205261, 17304050). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with tuberous sclerosis complex (PMID: 10533067, 29740858, 31855466). ClinVar contains an entry for this variant (Variation ID: 50083). For these reasons, this variant has been classified as Pathogenic.
Genome-Nilou Lab RCV000989436 SCV002040992 pathogenic Tuberous sclerosis 2 2021-11-07 criteria provided, single submitter clinical testing
3billion RCV000989436 SCV003842132 pathogenic Tuberous sclerosis 2 2023-02-23 criteria provided, single submitter clinical testing The variant is not observed in the gnomAD v2.1.1 dataset. This variant was predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (PMID: 10533067). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.
GeneDx RCV003153331 SCV003842499 pathogenic not provided 2023-03-15 criteria provided, single submitter clinical testing Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Identified in patients with a clinical diagnosis of tuberous sclerosis complex in a well-curated database (TSC2 LOVD); This variant is associated with the following publications: (PMID: 16114042, 10533067, 26252095, 29740858, 31855466)
Tuberous sclerosis database (TSC2) RCV000043349 SCV000067154 not provided Tuberous sclerosis syndrome no assertion provided curation
Tuberous sclerosis database (TSC2) RCV000043349 SCV000067155 not provided Tuberous sclerosis syndrome no assertion provided curation

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.